International travel by persons with medical comorbidities: Understanding risks and providing advice

Mayo Clinic Proceedings

Volumn 88, Issue 11, 2013, Pages 1231-1240

  Hochberg, Natasha S ^a,b   Barnett, Elizabeth D ^c   Chen, Lin H ^d   Wilson, Mary E ^e   Iyer, Hari ^b   MacLeod, William B ^b   Yanni, Emad ^f   Jentes, Emily S ^f   Karchmer, Adolf W ^g   Ooi, Winnie ^h   Kogelman, Laura ⁱ   Benoit, Christine ^c   Hamer, Davidson H ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d MOUNT AUBURN HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PRESCRIPTION DRUG; YELLOW FEVER VACCINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ENDEMIC DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL HISTORY; PATIENT COUNSELING; PREGNANCY; PRESCRIPTION; TRAVEL; TRAVELLER DIARRHEA; TYPHOID FEVER; UNITED STATES; YELLOW FEVER;

EID: 84888872912     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.07.018     Document Type: Article

References (46)

1. World Tourism Organization. International tourism 2010: multispeed recovery. http://85.62.13.114/media/news/en/press-det.php?id=7331&idioma=E. Accessed December 16, 2011.
2. International Trade Administration. U.S. Travel Abroad Declined Two Percent in 2010. Washington, DC: Dept of Commerce International Trade Administration; 2011. http://tinet.ita.doc.gov/outreachpages/download-data- table/2010-Outbound-Analysis.pdf. Accessed December 16, 2011.
3. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med. 2000;342(23):1716-1725.
4. Herman JS, Hill DR. Advising the traveller. Medicine. 2009;38(1): 56-59.
5. Van Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med. 2004;11(1):3-8.
6. Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med. 2004;11(1):23-26.
7. Kotton CN. Vaccination and immunization against travelrelated diseases in immunocompromised hosts. Expert Rev Vaccines. 2008;7(5):663-672.
8. Suh KN, Mileno MD. Challenging scenarios in a travel clinic: advising the complex traveler. Infect Dis Clin North Am. 2005; 19(1):15-47.
9. Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med. 2004;11(1):37-43.
10. Kemper CA, Linett A, Kane C, Deresinski SC. Travels with HIV: the compliance and health of HIV-infected adults who travel. Int J STD AIDS. 1997;8(1):44-49.
11. Franco-Paredes C, Hidron A, Tellez I, Lesesne J, Del Rio C. HIV infection and travel: pretravel recommendations and healthrelated risks. Top HIV Med. 2009;17(1):2-11.
12. Kofidis T, Pethig K, Rüther G, et al. Traveling after heart transplantation. Clin Transplant. 2002;16(4):280-284.
13. Spain MP, Edlund BJ. Travel immunization update for older adults. J Gerontol Nurs. 2010;36(4):9-12.
14. Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008; 86(3):407-412.
15. Roukens AH, van Dissel JT, de Fijter JW, Visser LG. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant. 2007;21(4):567-570.
16. Wieten RW, Leenstra T, Goorhuis A, van Vugt M, Grobusch MP. Health risks of travelers with medical conditionsda retrospective analysis. J Travel Med. 2012;19(2):104-110.
17. Baaten GG, Geskus RB, Kint JA, Roukens AH, Sonder GJ, van den Hoek A. Symptoms of infectious diseases in immunocompromised travelers: a prospective study with matched controls. J Travel Med. 2011;18(5):318-326.
18. Salit IE, Sano M, Boggild AK, Kain KC. Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ. 2005;172(7):884-888.
19. Hill DR, Ericsson CD, Pearson RD, et al; Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43(12):1499-1539.
20. Leder K, Weller PF, Wilson ME. Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis. 2001;33(9):1553-1566.
21. Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-7):1-27.
22. Centers for Disease Control and Prevention. CDC Health Information for International Travel 2012. Atlanta, GA: Centers for Disease Control and Prevention; 2011. http://wwwnc.cdc.gov/travel/yellowbook/2012/tableofcontents. htm.Accessed September 10, 2013.
23. Centers for Disease Control and Prevention. CDC Health Information for International Travel 2010. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
24. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82(5):346-353.
25. Chen LH, Wilson ME, Davis X, et al. Illness in long-term travelers visiting GeoSentinel clinics. Emerg Infect Dis. 2009; 15(11):1773-1782.
26. Freedman DO, Kozarsky PE, Weld LH, Cetron MS. GeoSentinel: the global emerging infections sentinel network of the International Society of Travel Medicine. J TravelMed. 1999;6(2):94-98.
27. Leder K, Tong S, Weld L, et al; GeoSentinel Surveillance Network. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43(9):1185-1193.
28. Wilson ME, Weld LH, Boggild A, et al; GeoSentinel Surveillance Network. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007; 44(12):1560-1568.
29. Freedman DO, Weld LH, Kozarsky PE, et al; GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006; 354(2):119-130.
30. Marano C, Freedman DO. Global health surveillance and travelers' health. Curr Opin Infect Dis. 2009;22(5):423-429.
31. Scoville SL, Bryan JP, Tribble D, et al. Epidemiology, preventive services, and illnesses of international travelers. Mil Med. 1997; 162(3):172-178.
32. LaRocque RC, Rao SR, Lee J, et al; Global TravEpiNet Consortium. Global TravEpiNet: a national consortium of clinics providing care to international travelersdanalysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis. 2012;54(4):455-462.
33. Lown BA, Chen LH, Wilson ME, et al. Vaccine administration decision making: the case of yellow fever vaccine. Clin Infect Dis. 2012;55(6):837-843.
34. Evans MR, Shickle D, Morgan MZ. Travel illness in British package holiday tourists: prospective cohort study. J Infect. 2001; 43(2):140-147.
35. Herwaldt BL, de Arroyave KR, Roberts JM, Juranek DD. A multiyear prospective study of the risk factors for and incidence of diarrheal illness in a cohort of Peace Corps volunteers in Guatemala. Ann Intern Med. 2000;132(12): 982-988.
36. Hezelgrave NL, Whitty CJ, Shennan AH, Chappell LC. Advising on travel during pregnancy. BMJ. 2011;342:d2506.
37. Castelli F, Patroni A. The human immunodeficiency virusinfected traveler. Clin Infect Dis. 2000;31(6):1403-1408.
38. Centers for Disease Control and Prevention: About the Yellow Fever Vaccine Course http://www.cdc.gov/travel-training/aboutyellow-fever-vaccine. html. Accessed November 7, 2011.
39. Carroll ID, Williams DC. Pre-travel vaccination and medical prophylaxis in the pregnant traveler. Travel Med Infect Dis. 2008;6(5):259-275.
40. Tsai TF, Paul R, Lynberg MC, Letson GW. Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis. 1993;168(6):1520-1523.
41. Nasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg. 1993;87(3):337-339.
42. Centers for Disease Control and Prevention: Recommendations and Guidelines: Guide to Vaccine Contraindications and Precautions. http://www.cdc.gov/vaccines/recs/vac-admin/contraindications.htm. Accessed November 16, 2011.
43. DuPont HL, Steffen R. Textbook of Travel Medicine and Health. Hamilton, Ontario: Decker; 2001.
44. Keystone JS, Kozarsky PE, Nothdurft HD, Freedman DO, Connor BA. Travel medicine. New York: Mosby; 2004.
45. Anderson S. Women's health and travel. In: Zuckerman JN, ed. Principles and Practice of Travel Medicine. Chichester, UK: John Wiley & Sons; 2001:381-422.
46. Committee to Advise on Tropical Medicine and Travel. The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2007;33(ACS-4):1-24.